Top Markets
Coin of the day
Orum Therapeutics, Inc. Orum Therapeutics, Inc.

Orum Therapeutics, Inc.

475830
Rank in Stocks #9664
Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the... Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.
Share Price
$45.64
Last synced: 2026-08-28
Market Cap
$969.02M
Change (1 day)
-1.20%
Change (1 year)
146.66%
Country
KR
Trade Orum Therapeutics, Inc. (475830)

Category

Price of 475830 with the market cap of B
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
475830
$45.64
Market Capitalization of Orum Therapeutics, Inc.(475830)
Market Cap: $969.02M
As of August 2026 Orum Therapeutics, Inc. has a market cap of $969.02M. This makes Orum Therapeutics, Inc. the world's 9664th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Orum Therapeutics, Inc. from 2025 to 2026
475830 compared with Top 5 Most Popular stocks
Price of 475830 Asset B Mkt. of B Results
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$247,917 $969.02M
$5.264T +543,118.35%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$221,420 $969.02M
$4.701T +485,060.24%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$196,736 $969.02M
$4.177T +430,974.59%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$179,792 $969.02M
$3.817T +393,846.51%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$134,998 $969.02M
$2.866T +295,698.99%